Immunogenicity of Ribosomal Vaccines Isolated from Group A, Type 14 Streptococcus pyogenes

A ribosomal preparation isolated from group A, type 14 Streptococcus pyogenes protected mice against a challenge of 1,000 mean lethal doses. Optimal immunization consisted of subcutaneous administration of 326 μg of protein with Freund incomplete adjuvant. Animals immunized with higher or lower anti...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Infect Immun
Autori principali:	Schalla, W. O., Johnson, W.
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1975
Soggetti:	Immunology
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC415199/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/806521/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.11.6.1195-1202.1975
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!